A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

August 31, 2006

Conditions
Pancreatic Cancer
Interventions
DRUG

CC-5013

DRUG

gemcitabine

Trial Locations (6)

29406

Charleston Cancer Center, Charleston

44106

Case Western Reserve University Hospitals Ireland Cancer Center, Cleveland

63110

Bernard Cancer Center, St Louis

70006

Cancer and Blood Institute, Metairie

77030

University of Texas MD Anderson Cancer Center, Houston

37203-1632

Sarah Cannon Cancer Center, Nashville

Sponsors
All Listed Sponsors
collaborator

Prologue Research International

INDUSTRY

lead

Celgene Corporation

INDUSTRY